AstraZeneca
AZN
#71
Rank
S$316.13 B
Marketcap
S$203.84
Share price
0.26%
Change (1 day)
-7.16%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): S$8.57

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is S$8.55. In 2024 the company made an earnings per share (EPS) of S$5.81 an increase over its 2023 EPS that were of S$4.92.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$8.57
2024S$5.8118.23%
2023S$4.9281.13%
2022S$2.71631.03%
2021S$0.37-88.11%
2020S$3.12136.89%
2019S$1.32-39.41%
2018S$2.18-28.27%
2017S$3.03-14.37%
2016S$3.5424.11%
2015S$2.86127.55%
2014S$1.25-51.96%
2013S$2.61-58.95%
2012S$6.36-32.2%
2011S$9.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.18 30.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$8.53-0.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.97-88.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$3.99-53.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$38.26 347.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.44-71.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$7.27-14.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.62-81.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.81-32.04%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.09-52.13%๐Ÿ‡ฌ๐Ÿ‡ง UK